↓ Skip to main content

Decitabine-Mediated Epigenetic Reprograming Enhances Anti-leukemia Efficacy of CD123-Targeted Chimeric Antigen Receptor T-Cells

Overview of attention for article published in Frontiers in immunology, August 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
66 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Decitabine-Mediated Epigenetic Reprograming Enhances Anti-leukemia Efficacy of CD123-Targeted Chimeric Antigen Receptor T-Cells
Published in
Frontiers in immunology, August 2020
DOI 10.3389/fimmu.2020.01787
Pubmed ID
Authors

Liangshun You, Qingmei Han, Li Zhu, Yijing Zhu, Changqian Bao, Chunmei Yang, Wen Lei, Wenbin Qian

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 66 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 12%
Researcher 8 12%
Student > Bachelor 7 11%
Student > Ph. D. Student 6 9%
Student > Postgraduate 4 6%
Other 10 15%
Unknown 23 35%
Readers by discipline Count As %
Medicine and Dentistry 12 18%
Biochemistry, Genetics and Molecular Biology 9 14%
Agricultural and Biological Sciences 7 11%
Immunology and Microbiology 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 7 11%
Unknown 24 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 September 2020.
All research outputs
#7,638,838
of 26,163,973 outputs
Outputs from Frontiers in immunology
#8,972
of 33,001 outputs
Outputs of similar age
#157,777
of 429,836 outputs
Outputs of similar age from Frontiers in immunology
#314
of 852 outputs
Altmetric has tracked 26,163,973 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 33,001 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,836 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 852 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.